TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05591716

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Bilateral same-session flexible ureterorenoscopy
Description: The patient was in the lithotomic position. A semi-rigid ureteroscope was passed into the bladder, then a roadrunner was placed. A flexible urethroscope is guided along the roadrunner to the kidney. In the kidney, the concrement is fragmented with laser energy. The fragments were extracted using a basket. Then a revision of the kidney is performed using a flexible urethroscope. A ureteral stent was placed in the pelvis.The ureteroscope was extracted together with the case with the ureteral revision: there was no damage to the ureter.Next, this procedure is performed from the other side. Urine was excreted from the bladder using a Nelaton catheter.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Unilateral same-session flexible ureterorenoscopy
Description: The patient was in the lithotomic position. A semi-rigid ureteroscope was passed into the bladder, then a roadrunner was placed. A flexible urethroscope is guided along the roadrunner to the kidney. In the kidney, the concrement is fragmented with laser energy. The fragments were extracted using a basket. Then a revision of the kidney is performed using a flexible urethroscope. A ureteral stent was placed in the pelvis. The ureteroscope was extracted together with the body with revision of the ureter: there was no damage to the ureter. Urine was excreted from the bladder using a Nelaton catheter.
Study: NCT06464419

Intervention type: DEVICE
Intervention: ultrasound
Description: Measurement of optic nerve sheath diameter by ultrasound
Study: NCT05350189

Intervention type: DRUG
Intervention: Gadobutrol (Gadavist/Gadovist, BAY86-4875)
Description: At discretion of attending physician

Intervention type: DRUG
Intervention: Gadobutrol (Gadavist/Gadovist, BAY86-4875)
Description: At discretion of attending physician
Study: NCT06502834

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: D piger
Description: Probiotic d piger

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study: NCT05556538

Intervention type: PROCEDURE
Intervention: Transforaminal Epidural Steroid Injection
Description: Patients are placed in the prone position, with a pillow under their abdomen (to reduce lumbar lordosis) and taken to the operating table. The procedure area is cleaned 3 times with povidone-iodine antiseptic and covered with a sterile cover. In order to view the foramen to be processed, the fluoroscopy arm is evaluated at AP-oblique / cranial or caudal angles to obtain an optimal image. Local anesthetic (3 cc 2% prilocaine) is injected into the skin and subcutaneous tissue. The spinal Quincke 21-gauge 90 mm needle is advanced by targeting the relevant foramen under the guidance of fluoroscopy image. Needle position is confirmed by taking a lateral view. Needle aspiration is checked for blood. 1-2 ml of contrast material is injected to confirm that there is no vascular distribution and that it is in the epidural space. When distribution without vascular invasion is observed, an injection of a mixture of 10 mg dexamethasone, 1 cc saline and 1 cc (0.5%) bupivacaine is performed.

Intervention type: PROCEDURE
Intervention: Transforaminal Epidural Steroid Injection
Description: Patients are placed in the prone position, with a pillow under their abdomen (to reduce lumbar lordosis) and taken to the operating table. The procedure area is cleaned 3 times with povidone-iodine antiseptic and covered with a sterile cover. In order to view the foramen to be processed, the fluoroscopy arm is evaluated at AP-oblique / cranial or caudal angles to obtain an optimal image. Local anesthetic (3 cc 2% prilocaine) is injected into the skin and subcutaneous tissue. The spinal Quincke 21-gauge 90 mm needle is advanced by targeting the relevant foramen under the guidance of fluoroscopy image. Needle position is confirmed by taking a lateral view. Needle aspiration is checked for blood. 1-2 ml of contrast material is injected to confirm that there is no vascular distribution and that it is in the epidural space. When distribution without vascular invasion is observed, an injection of a mixture of 10 mg dexamethasone, 1 cc saline and 1 cc (0.5%) bupivacaine is performed.
Study: NCT04038515

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nicotine 24 mg/mL
Description: E-liquid containing high nicotine ( 24 mg/mL nicotine) will be self-administered via e-cigarettes. This will be administered in 5 flavor conditions (1 unflavored, 2 menthol, and 2 fruit conditions).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nicotine 24 mg/mL
Description: E-liquid containing high nicotine ( 24 mg/mL nicotine) will be self-administered via e-cigarettes. This will be administered in 5 flavor conditions (1 unflavored, 2 menthol, and 2 fruit conditions).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nicotine 24 mg/mL
Description: E-liquid containing high nicotine ( 24 mg/mL nicotine) will be self-administered via e-cigarettes. This will be administered in 5 flavor conditions (1 unflavored, 2 menthol, and 2 fruit conditions).

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 'Menthol' flavor
Description: E-liquid containing 'menthol' flavor will be self-administered via e-cigarettes. This will be administered in 4 nicotine conditions (0, 6, 12, 24 mg/mL nicotine).

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 'Menthol' flavor
Description: E-liquid containing 'menthol' flavor will be self-administered via e-cigarettes. This will be administered in 4 nicotine conditions (0, 6, 12, 24 mg/mL nicotine).
Study: NCT05660447

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Netarsudil 0.02% Ophthalmic Solution [RHOPRESSA]
Description: One drop of rho-kinase (ROCK) inhibitor in the vitrectomized eye, once daily in the evening starting on postoperative day 1 after RRD repair surgery, till post-operative day 56

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Glycerin 0.2%/Hypromellose 0.2%/Peg 1%/Soln,Oph,Ud
Description: Patients enrolled in the control group will receive a placebo (one drop of artificial tears) once daily in the evening starting on postoperative day 1 after RRD repair surgery, till post-operative day 56
Study: NCT06037408

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 20mM sodium pyruvate nasal spray
Description: The product is a 20 mM (0.2%, 2.2 mg/mL) sodium pyruvate nasal spray in 0.9% sodium chloride with benzalkonium chloride preservative, pH 7.2 (N115). Subjects will self-administer 3 squirts per nostril of the nasal spray, 3 times daily; upon wakening, noon/midday, and before bedtime.
Study: NCT05949697

Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: Dry Eye Drink
Description: Dry Eye Drink is a dietary supplement containing electrolytes, vitamins and natural anti-inflammatories.
Study: NCT06037408

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Saline Placebo control nasal spray
Description: The placebo is 0.9% sodium chloride with benzalkonium chloride preservative, pH 7.2. Subjects will self-administer 3 squirts per nostril of the nasal spray, 3 times daily; upon wakening, noon/midday, and before bedtime.
Study: NCT04038515

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 'Menthol' flavor
Description: E-liquid containing 'menthol' flavor will be self-administered via e-cigarettes. This will be administered in 4 nicotine conditions (0, 6, 12, 24 mg/mL nicotine).
Study: NCT06124456

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Usual Care Control Group
Description: Subjects in the usual care control group will receive health education as the attention control. The program will consist of eight 150-minute bi-weekly sessions covering major health issues relating to general health and NAFLD, to be obtained from publicly accessible resources from the Hong Kong Department of Health. Health education information on non-communicable diseases (e.g., cancers, diabetes, coronary heart diseases, obesity, and mental illness), infectious diseases (e.g., COVID-19), and a healthy lifestyle (e.g., balanced diet, physical activity, good sleep, tobacco use, alcohol cessation, and stress management) will also be distributed to the subjects in the exercise groups through recorded presentation videos and leaflets/pamphlets during the first 16 weeks.
Study: NCT06100406

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Biofield tuning
Description: Biofield Tuning is a non-invasive, non-medical therapeutic practice in which a resonating tuning fork is used to identify and re-balance off-the-body sites at which perturbations in the tuning fork sound are detected.
Study: NCT06510972

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Strategy for continuing oral intake
Description: Patients will be able to ingest liquids or solid food orally, at any frequency and in any quantity they wish, according to their tolerance, with paramedical assistance if necessary.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Fasting strategy
Description: The patient will not be able to ingest liquids or solid food.
Study: NCT06093490

Intervention type: DEVICE
Intervention: Eysz Hyperventilation Recorder
Description: App used to guide and record hyperventilation

Intervention type: DEVICE
Intervention: Eysz Hyperventilation Recorder
Description: App used to guide and record hyperventilation
Study: NCT06124456

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Moderate-intensity Exercise Intervention
Description: The walking time in each session will be 50 minutes for the moderate-intensity group. The overall weekly exercise volume for the two groups will be the same based on total energy expenditure, as per the WHO's physical activity recommendation (150 minutes of moderate-intensity physical activity weekly is equivalent to 75 minutes of vigorous-intensity physical activity weekly). Five minutes of walking at a normal pace will be included for warm-up and cool-down.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Vigorous-intensity Exercise Intervention
Description: The walking time in each session will be 25 minutes for the vigorous-intensity group. The overall weekly exercise volume for the two groups will be the same based on total energy expenditure, as per the WHO's physical activity recommendation (150 minutes of moderate-intensity physical activity weekly is equivalent to 75 minutes of vigorous-intensity physical activity weekly). Five minutes of walking at a normal pace will be included for warm-up and cool-down.
Study: NCT05492175

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: robotic practice
Description: According to the group assignment, participants will start from the BMT proximal mode (i.e., forearm pronation-supination movement), and then the distal mode (i.e., wrist flexion-extension movement), and vice versa. Each participant is expected to complete approximately 400 to 600 repetitions of the proximal mode session (i.e., forearm movements) and another 400 to 600 repetitions of the distal mode session (i.e., wrist movements), respectively.
Study: NCT03718858

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Interscalene Block
Description: 15 mL ropivacaine 0.5% will be injected in 5 mL aliquots in order to achieve spread adjacent to C5 and C6 nerve roots.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Superior Trunk Nerve Block
Description: 15 mL ropivacaine 0.5% will be injected in 5 mL aliquots in order to achieve spread adjacent to Superior Trunk Nerve.
Study: NCT04927572

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FMX114
Description: Active Comparator
Study: NCT05778409

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Cordyceps cicadae extract
Description: 500mg/ day for one month
Study: NCT04927572

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Vehicle
Description: Placebo Comparator
Study: NCT06198686

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nalmefene
Description: Opioid antagonist

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nalmefene
Description: Opioid antagonist
Study: NCT05490966

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: isometric trunk extensor muscles fatigue
Description: Participants will perform three sets of intermittent isometric efforts between 50 and 60 percents of their maximal isometric strength. A padded force sensor will be placed approximately at the level of the 7th thoracic vertebrae. The first two sets will last six minutes each, while the third set will last three minutes. Between each set participants will rest for two minutes.
Study: NCT05082727

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: KOVIR (TD0068) oral softgel
Description: KOVIR (TD0068) is a softgel containing Allium sativum extract 270mg, Colostrum156.4 mg, fine powder mixed herbs 43.6mg

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo oral softgel
Description: Placebo
Study: NCT05632926

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 40 mg CBL-514
Description: CBL-514 will be administered at the raised area of cellulite.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 60 mg CBL-514
Description: CBL-514 will be administered at the raised area of cellulite.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 80 mg CBL-514
Description: CBL-514 will be administered at the raised area of cellulite.
Study: NCT06264297

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Radiofrequency
Description: Pulsed radiofrequency (PRF) is a nonablative pain treatment that uses radiofrequency current in short high-voltage bursts, resulting in interruption of nociceptive afferent pathways. This study aims to show how the variation in radiofrequency voltage applied to the dorsal root ganglion (DRG) affects the treatment of neuropathic pain.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Radiofrequency
Description: Pulsed radiofrequency (PRF) is a nonablative pain treatment that uses radiofrequency current in short high-voltage bursts, resulting in interruption of nociceptive afferent pathways. This study aims to show how the variation in radiofrequency voltage applied to the dorsal root ganglion (DRG) affects the treatment of neuropathic pain.
Study: NCT05176756

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Gamification and Social Support
Description: Participants will be entered into a points and levels-based game designed to help them meet their step count goals. At the start of each week, the participant will receive a set amount of points. Each day their step goal is not met, they lose points. If the participant meets a certain point value at the end of the week, they will either advance one level (of five total levels); if they do not, they will drop one level. Each participant will also select a family member or friend or the study coordinator to serve as a support partner. At the beginning of the intervention, the participant and support partner will identify at least 3 ways in which they can help the participant meet their step goals. This partner will receive a weekly email reminding them of these approaches and updating them on the participant's progress.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Attention control
Description: Participants will receive a daily text message with their step count from the day prior.
Study: NCT05399823

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise
Description: Strecthing exercises will given for 15-20 minutes everyday for four weeks

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Strecthing exercises will given for 15-20 minutes everyday for four weeks

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Exercise
Description: Strecthing exercises will given for 15-20 minutes everyday for four weeks
Study: NCT05873933

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hemptress Oil
Description: Full ingredient list of the test product: Rubus occidentalis (Black raspberry) seed oil\*, Carica papaya (Papaya) seed oil\*, Bixa orellana (Annatto) seed oil\*, Orbignya oleifera (Babassu) seed oil\*, Borago officinalis (Bourrache) seed oil\*, Daucus carota (Carrot) seed oil\*, Hibiscus sabdariffa (Hibiscus) seed oil\*, Aronia melanocarpa (Chokeberry) seed oil\*, Vaccinium macrocarpon (Cranberry) seed oil\*, Moringa oleifera (Moringa) seed oil\*\*, Persea americana (Avocado) oil\*, Ribes nigrum (Black currant) seed oil\*, Copaifera officinalis (Copaiba) resin\*, Canabis sativa (Hemp) seed oil\*, Moringa peregrina seed oil extract \& Caprylic/Capric Triglyceride\*\* (Moringa peregrina extract), Ascorbyl tetraisopalmitate (Vitamin C), Proprietary full-spectrum blend of Cannabis sativa (Hemp) extract, Silica (Algica), Ergocalciferol (Vitamin D2), Menaquinone (Vitamin K2), Tocopherol (Vitamin E)\* Organic Ingredient\* Wild Crafted/Regenerative\*\*

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hemptress Oil
Description: Full ingredient list of the test product: Rubus occidentalis (Black raspberry) seed oil\*, Carica papaya (Papaya) seed oil\*, Bixa orellana (Annatto) seed oil\*, Orbignya oleifera (Babassu) seed oil\*, Borago officinalis (Bourrache) seed oil\*, Daucus carota (Carrot) seed oil\*, Hibiscus sabdariffa (Hibiscus) seed oil\*, Aronia melanocarpa (Chokeberry) seed oil\*, Vaccinium macrocarpon (Cranberry) seed oil\*, Moringa oleifera (Moringa) seed oil\*\*, Persea americana (Avocado) oil\*, Ribes nigrum (Black currant) seed oil\*, Copaifera officinalis (Copaiba) resin\*, Canabis sativa (Hemp) seed oil\*, Moringa peregrina seed oil extract \& Caprylic/Capric Triglyceride\*\* (Moringa peregrina extract), Ascorbyl tetraisopalmitate (Vitamin C), Proprietary full-spectrum blend of Cannabis sativa (Hemp) extract, Silica (Algica), Ergocalciferol (Vitamin D2), Menaquinone (Vitamin K2), Tocopherol (Vitamin E)\* Organic Ingredient\* Wild Crafted/Regenerative\*\*
Study: NCT06511310

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: High Intensity Exercise
Study: NCT00610337

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cethrin® (BA-210)
Description: Intraoperative epidural administration during spinal decompression surgery
Study: NCT06208566

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Conversational Agent Zenny
Description: The intervention group involves a newly developed conversational agent self-care program. This program consists of 40 separate modules based on empirically supported techniques. Modules include the following core sections: cognitive behavioral skills, interpersonal relationships, positive psychological growth, relaxation, goal setting, and emotional regulation skills. The modules focus on cognitive-behavioral skills for reducing emotional distress, improving behavioral activation and healthy behaviors, and problem-solving skills. The intervention was delivered via a decision-tree based conversational agent in WhatsApp messenger.
Study: NCT04745403

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: mRNA HBV/TCR T-cells
Description: Study Infusion~The first dose of mRNA HBV-TCR T-cells at dose 1x10e5/kg BW will be infused on Day 0, and subsequently incremental doses on Day 14 and 28, up to the dose of 5-10x10e6/kg BW.
Study: NCT06208566

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Web-based Wellness Resources
Description: The control group involved referral to a menu of freely-available evidence-based wellness resources linked from the study website, Your Healthiest Self: Wellness Toolkits, Doing What Matters in Times of Stress, and How Right Now. These website choices involved self-selection of relevant modules for improving mood, reducing stress and anxiety, addressing relationship problems, and other wellness topics. These programs required only access to the websites and could be completed in a self-help format by participants at their own pace.
Study: NCT04708860

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Prolonged Nightly Fasting
Description: Restriction of consumption of calorie-containing food/drinks after 8pm

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Personalized moderate-intensity, aerobic exercise and strength training
Study: NCT05515939

Intervention type: DEVICE
Intervention: InPen Insulin Pen
Description: The InPen is a reusable smart insulin pen for people living with diabetes. The device uses Bluetooth technology to send dose information to a mobile application. The InPen can be used to deliver insulin, help calculate insulin doses, and estimate carbohydrates for meals
Study: NCT06089941

Intervention type: OTHER
Intervention: circulating tumoral DNA detection
Description: blood samples taken at diagnosis, mid-treatment, end of treatment and in the event of relapse
Study: NCT00610337

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cethrin® (BA-210)
Description: Intraoperative epidural administration during spinal decompression surgery

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cethrin® (BA-210)
Description: Intraoperative epidural administration during spinal decompression surgery

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cethrin® (BA-210)
Description: Intraoperative epidural administration during spinal decompression surgery

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Spinal decompression surgery without administration of Cethrin® BA-210
Study: NCT06358794

Intervention type: DIAGNOSTIC_TEST
Intervention: Machine learning-based predictive model
Description: The clinical features of participants were used to train, test and validate the machine learning models. Various evaluation metrics including area under the ROC (AUC), accuracy, etc. were used to evaluate the predictive performance of 8 machine learning models.
Study: NCT06510400

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: OMNICHROMA
Description: supra nano filled composite

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: OMNICHROMA
Description: supra nano filled composite

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ceram. x spectra
Description: nano hybrid composite resin

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ceram. x spectra
Description: nano hybrid composite resin
Study: NCT06454149

Intervention type: OTHER
Intervention: MALT lymphoma
Description: New diagnosis with gastric MALT lymphoma
Study: NCT04994093

Intervention type: OTHER
Intervention: Collection of blood (PBMC), biopsy (FFPE) and stool samples.
Description: Patients receiving routine treatment financed by the Polish National Health Fund (NFZ).